1. Home
  2. SANM vs ARWR Comparison

SANM vs ARWR Comparison

Compare SANM & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanmina Corporation

SANM

Sanmina Corporation

BUY

Current Price

$155.60

Market Cap

13.3B

Sector

Technology

ML Signal

BUY

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$58.24

Market Cap

12.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SANM
ARWR
Founded
1980
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
12.4B
IPO Year
1994
2009

Fundamental Metrics

Financial Performance
Metric
SANM
ARWR
Price
$155.60
$58.24
Analyst Decision
Hold
Strong Buy
Analyst Count
4
15
Target Price
★ $262.50
$107.36
AVG Volume (30 Days)
591.4K
★ 1.7M
Earning Date
11-09-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
14.07
★ 99.80
EPS
★ 4.71
N/A
Revenue
★ $7,890,475,000.00
$16,142,321.00
Revenue This Year
$74.08
N/A
Revenue Next Year
$18.06
N/A
P/E Ratio
$32.82
★ N/A
Revenue Growth
★ 16.78
N/A
52 Week Low
$118.10
$37.06
52 Week High
$288.68
$95.49

Technical Indicators

Market Signals
Indicator
SANM
ARWR
Relative Strength Index (RSI) 28.15 33.24
Support Level $138.52 $54.96
Resistance Level $164.83 $66.37
Average True Range (ATR) 10.07 2.28
MACD -6.56 0.53
Stochastic Oscillator 7.19 33.40

Price Performance

Historical Comparison
SANM
ARWR

About SANM Sanmina Corporation

Sanmina Corp is a provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers in the communications networks, storage, industrial, defense, and aerospace end markets. The operations are managed as two businesses: Integrated Manufacturing Solutions, which consists of printed circuit board assembly and represents a majority of the firm's revenue; and Components, Products, and Services, which includes interconnect systems and mechanical systems. The firm generates revenue mainly in the United States, China, and Mexico, but has a presence around the world.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Share on Social Networks: